Stock Evaluator: Materialise NV (MTLS)

Materialise NV MTLS

$6.35 -0.06 -0.94%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 56,756
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Information Technology Software

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

Commentary & Analysis


Financial Summary

Share Statistics MTLS Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $369.9 $977.4 34%
Shares Out (Mil) 69.4 78.1 55%
Institutional Ownership 84.8% 79.0% 53%
Float (Mil) 24.1 57.6 32%
Beta 1.28 1.03 74%
Avg Daily Volume (000s) 64 750 31%
Price Change
(52-week)
21.0% 56.5% 62%
Growth MTLS Industry
Median
Percentile
(All Stocks)
Sales (5yr) 8.5% 14.8% 52%
Net Income (5yr) 25.1% 10.1% 80%
EPS (5yr) 24.2% 16.2% 74
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) 29.5% (15.3%) 86%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 2 3
Current EPS $0.046 $0.210 $0.285
Month Ago EPS $0.046 $0.210 $0.285
# Rev Up 0 0 1
# Rev Down 1 1 0
Three Months Ago EPS $0.035 $0.138 $0.253
Year/Year Chg (60.7%) 37.3% 190.2%
Financials MTLS Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $314 $348 37%
Net Income (TTM) (Mil) $9 ($2) 45%
EPS (TTM) $0.153 ($0.100) 45%
Operating Cash Flow (TTM) (Mil) $30 $30 44%
Net Cash Flow (TTM) (Mil) ($30) $0 23%
Long-Term Debt (Q1) (Mil) $62 $35 41%
Enterprise Value (Q1) (Mil) $245 $1,019 28%
Valuation MTLS Industry
Median
Percentile
(All Stocks)
P/B 1.25 3.24 32%
P/E 41.5 34.8 79%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) 1.7 2.1 63%
Ratios MTLS Industry
Median
Percentile
(All Stocks)
Gross Margin 57.6% 70.5% 70%
Net Margin 3.8% 0.6% 45%
ROA 1.9% (1.6%) 55%
ROE 3.2% 1.6% 40%
Liabilities to Assets 39.3% 46.1% 30%
F-Score 7 5 84%

Materialise NV did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors